Fundraising FoxWaiv
9 known investors
Find your way into Waiv
Sign up to see every warm intro you have to Waiv
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Waiv team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Waiv provides AI-powered digital pathology services for biopharma companies, offering co-development partnerships that span AI biomarker discovery, algorithm validation, SaMD development, regulatory strategy (CE-IVD/FDA), and companion diagnostic commercialization. Its tools support clinical trial patient screening, stratification, endpoint development, and lab adoption of precision oncology tests.
Investors · 9
How we know: funding news · thesaasnews.com · Not right? Tell us
How we know: funding news · thesaasnews.com · Not right? Tell us
How we know: funding news · thesaasnews.com · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$33M disclosed across 1 of 2 rounds · 2026
- Undisclosed amountSeries AApr 2026
CRB Digital Health III (lead), Alpha Intelligence Capital, CRB Health Tech, Karista, OTB Ventures, Serena Data Ventures, SistaFund
Source ↗ - $33MraisedMar 2026 · 4 sources
Alpha Intelligence Capital (lead), OTB Ventures (lead), Karista, Serena Data Ventures, SistaFund
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Waiv do?
- Waiv provides AI-powered digital pathology services for biopharma companies, offering co-development partnerships that span AI biomarker discovery, algorithm validation, SaMD development, regulatory strategy (CE-IVD/FDA), and companion diagnostic commercialization. Its tools support clinical trial patient screening, stratification, endpoint development, and lab adoption of precision oncology tests.
- Who are Waiv's investors?
- Waiv's investors include Serena, Sista, Alpha Intelligence Capital, Karista, OTB Ventures, Serena Ventures.
- How much funding has Waiv raised?
- Waiv has disclosed $33M raised across 1 of its 2 known rounds.